AAAAAA
Results:
1-8
|
Results: 8
Authors:
Persson, KEM
Hillarp, A
Dahlback, B
Citation: Kem. Persson et al., Analytical considerations for free protein S assays in protein S deficiency, THROMB HAEM, 86(5), 2001, pp. 1144-1147
Authors:
Emmerich, J
Rosendaal, FR
Cattaneo, M
Margaglione, M
De Stefano, V
Cumming, T
Arruda, V
Hillarp, A
Reny, JL
Citation: J. Emmerich et al., Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including2310 cases and 3204 controls, THROMB HAEM, 86(3), 2001, pp. 809-816
Authors:
Larsson, J
Hultberg, B
Hillarp, A
Citation: J. Larsson et al., Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion, ACT OPHTH S, 78(3), 2000, pp. 340-343
Authors:
Larsson, J
Hillarp, A
Olafsdottir, E
Bauer, B
Citation: J. Larsson et al., Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion, ACT OPHTH S, 77(6), 1999, pp. 634-637
Authors:
Zoller, B
de Frutos, PG
Hillarp, A
Dahlback, B
Citation: B. Zoller et al., Thrombophilia as a multigenic disease, HAEMATOLOG, 84(1), 1999, pp. 59-70
Authors:
Holm, J
Hillarp, A
Zoller, B
Erhardt, L
Berntorp, E
Dahlback, B
Citation: J. Holm et al., Factor V Q(506) (resistance to activated protein C) and prognosis after acute coronary syndrome, THROMB HAEM, 81(6), 1999, pp. 857-860
Authors:
Larsson, J
Hillarp, A
Citation: J. Larsson et A. Hillarp, The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism Pl(A2) in patients with central retinal vein occlusion, THROMB RES, 96(4), 1999, pp. 323-327
Authors:
Holm, J
Hillarp, A
Erhardt, L
Berntorp, E
Citation: J. Holm et al., Changes in levels of factor VII and protein S after acute myocardial infarction: Effects of low-dose warfarin, THROMB RES, 96(3), 1999, pp. 205-212
Risultati:
1-8
|